Al-Madhi Sara, Abu Hilal Mohammad, Acciuffi Sara, Rahimli Mirhasan, Jeong Seong, Rawicz-Pruszyński Karol, Chouillard Marc-Anthony, Messaoudi Nouredin, Chouillard Elie, Dagher Ibrahim, Croner Roland S, Gumbs Andrew A
Department of General, Visceral, Vascular and Transplantation Surgery, University of Magdeburg, 39120 Magdeburg, Germany.
Department of Surgery, University Hospital Southampton NHS Foundation Trust, Southhampton SO16 6YD, UK.
Cancers (Basel). 2025 Aug 15;17(16):2659. doi: 10.3390/cancers17162659.
: SIMPLR-2 is a follow-up to the international, multicenter SIMPLR-1 study evaluating long-term oncological outcomes after open (OLP), laparoscopic (LLP), and robotic (RLP) left pancreatectomy for pancreatic ductal adenocarcinoma (PDAC). : A retrospective analysis of 71 PDAC patients from three high-volume centers was performed. Surgical approaches were stratified into open, laparoscopic, and robotic. The primary endpoint was overall survival (OS); recurrence-free survival (RFS) was also assessed. Kaplan-Meier and Cox regression analyses were used, including propensity score adjustment. : Median OS was 11.0 months for OLP and 24.0 months for minimally invasive approaches ( = 0.169). Median RFS was 6 vs. 15 months, respectively ( = 0.258). No significant differences were found between surgical approaches. : Although longer survival was observed in minimally invasive groups, differences were not statistically significant. Larger prospective trials are needed to clarify the long-term oncologic impact of a surgical approach in PDAC.
SIMPLR-2是一项针对国际多中心SIMPLR-1研究的后续研究,该研究评估了开放性(OLP)、腹腔镜(LLP)和机器人辅助(RLP)左半胰切除术治疗胰腺导管腺癌(PDAC)后的长期肿瘤学结局。对来自三个高容量中心的71例PDAC患者进行了回顾性分析。手术方式分为开放、腹腔镜和机器人辅助。主要终点是总生存期(OS);还评估了无复发生存期(RFS)。采用Kaplan-Meier法和Cox回归分析,包括倾向评分调整。OLP组的中位OS为11.0个月,微创组为24.0个月(P = 0.169)。中位RFS分别为6个月和15个月(P = 0.258)。手术方式之间未发现显著差异。虽然微创组观察到生存期更长,但差异无统计学意义。需要更大规模的前瞻性试验来阐明手术方式对PDAC的长期肿瘤学影响。